"Hope Is Not an Investment Strategy," Says the Lone Wall Street Analyst Who Hasn't Been Wrong About SpaceX

SpaceX stock has fallen 15% below its IPO price and 50% from its all-time high, with 37 of 38 Wall Street analysts rating it a buy or hold. However, CFRA analyst Keith Snyder's sell rating and $115 price target have proven prescient. Snyder argues that SpaceX's $28.5 trillion addressable market claim is questionable, the company lacks recurring profits despite positive adjusted EBITDA, and Elon Musk's history of unfulfilled promises (Tesla's Level 5 autonomy, robotaxis) suggests investors shouldn't rely on hope when valuing the stock.